We are live on ! Find out more
ACB

Aristotle Capital Boston Portfolio holdings

AUM $1.61B
1-Year Est. Return 19.82%
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
+19.82%
3 Year Est. Return
+51.6%
5 Year Est. Return
+74.11%
10 Year Est. Return
+400.29%
AUM
$3.29B
AUM Growth
+$22.1M
Cap. Flow
-$118M
Cap. Flow %
-3.59%
Top 10 Hldgs %
20.16%
Holding
132
New
1
Increased
26
Reduced
101
Closed
4

Sector Composition

Rank Sector Weight
1 Industrials 25.46%
2 Technology 19.62%
3 Healthcare 16.08%
4 Financials 12.95%
5 Consumer Discretionary 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AER icon
1
AerCap
AER
$23.4B
$77.4M 2.35%
890,393
-31,492
-3% -$2.47M
ITRI icon
2
Itron
ITRI
$4.48B
$72.5M 2.2%
783,355
-21,471
-3% -$1.73M
ACHC icon
3
Acadia Healthcare
ACHC
$2.55B
$71.8M 2.18%
906,068
-22,077
-2% -$1.81M
DY icon
4
Dycom Industries
DY
$11.2B
$66.4M 2.02%
462,688
-14,307
-3% -$1.76M
HURN icon
5
Huron Consulting
HURN
$2.71B
$66.4M 2.02%
687,069
-2,207
-0.3% -$224K
MMSI icon
6
Merit Medical Systems
MMSI
$4.82B
$64.6M 1.96%
853,312
-16,172
-2% -$1.25M
MTSI icon
7
MACOM Technology Solutions
MTSI
$17.4B
$64.2M 1.95%
670,749
-19,373
-3% -$1.71M
EFOR
8
Everforth Inc
EFOR
$960M
$60.2M 1.83%
575,091
-18,061
-3% -$1.75M
AZEK
9
DELISTED
The AZEK Co
AZEK
$60.2M 1.83%
1,199,183
-37,770
-3% -$1.65M
CHE icon
10
Chemed
CHE
$7.16B
$60.2M 1.83%
93,753
-3,107
-3% -$1.89M
AEIS icon
11
Advanced Energy
AEIS
$10.1B
$53.6M 1.63%
525,800
-15,092
-3% -$1.54M
BDC icon
12
Belden
BDC
$3.97B
$51.3M 1.56%
553,532
-14,954
-3% -$1.22M
PBH icon
13
Prestige Consumer Healthcare
PBH
$2.47B
$51.1M 1.55%
704,156
-17,196
-2% -$1.15M
WAB icon
14
Wabtec
WAB
$49.3B
$48M 1.46%
329,307
-5,551
-2% -$752K
AIN icon
15
Albany International
AIN
$2.09B
$47.8M 1.45%
511,242
-14,818
-3% -$1.36M
HQY icon
16
HealthEquity
HQY
$8.71B
$47.6M 1.44%
582,663
-16,729
-3% -$1.31M
SUM
17
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$47.3M 1.43%
1,060,338
-30,652
-3% -$1.21M
ACIW icon
18
ACI Worldwide
ACIW
$6.12B
$47.2M 1.43%
1,422,623
-37,184
-3% -$1.15M
CRI icon
19
Carter's
CRI
$1.43B
$46.9M 1.42%
554,144
-12,827
-2% -$1.02M
BWIN
20
Baldwin Insurance Group
BWIN
$2.75B
$44.7M 1.36%
1,545,856
+26,166
+2% +$687K
NBHC icon
21
National Bank Holdings
NBHC
$1.9B
$44.3M 1.35%
1,228,969
-31,865
-3% -$1.11M
EEFT icon
22
Euronet Worldwide
EEFT
$3.19B
$44M 1.33%
399,830
+2,118
+0.5% +$222K
KBR icon
23
KBR
KBR
$4.56B
$43.6M 1.32%
685,302
+439
+0.1% +$25K
HASI icon
24
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.81B
$42.6M 1.29%
1,501,266
+920
+0.1% +$23K
BOX icon
25
Box
BOX
$4.49B
$41.5M 1.26%
1,466,201
-1,574
-0.1% -$42.3K

Similar funds

Aristotle Capital Boston's Q1 2024 Portfolio in Review

As of Q1 2024, Aristotle Capital Boston held 132 positions worth $3.29B, up 0.68% from $3.27B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Aristotle Capital Boston withdrew a net $118M in Q1 2024, closing 4 positions and reducing 101 holdings. Its most notable exit was SP Plus Corporation, an estimated $23.2M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Aristotle Capital Boston opened a new position in PowerSchool Holdings, Inc. worth $4.75M.

  • Aristotle Capital Boston's largest Q1 2024 buy was PowerSchool Holdings, Inc.: 223,296 shares worth $4.75M.
  • Aristotle Capital Boston added most to Knowles in Q1 2024, an estimated $4.5M increase.
  • Aristotle Capital Boston's biggest Q1 2024 reduction was AZZ Inc, cutting an estimated $13.1M.
  • Aristotle Capital Boston fully exited SP Plus Corporation in Q1 2024, selling an estimated $23.2M.
  • Aristotle Capital Boston's ten largest holdings make up 20% of its $3.29B portfolio in Q1 2024.
  • Aristotle Capital Boston opened 1 new position and closed 4 in Q1 2024.
  • Aristotle Capital Boston's portfolio value rose 0.68% quarter-over-quarter to $3.29B.

Based on Aristotle Capital Boston's 13F filing for Q1 2024, filed 15 May 2024.